Evidence map›Paper›PMID 40207066›Full record

ArticleMethodsX2025

Prediction of stock market using sentiment analysis and ensemble learning.

Dr Archana Y Chaudhari, Dr Smita Mahajan

Abstract read
In one paragraph

Article in MethodsX, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dr Archana Y ChaudhariArtificial Intelligence & Machine Learning Department, Symbiosis Institute of Technology, Pune Campus, Symbiosis International (Deemed University), Pune, India.
Dr Smita MahajanArtificial Intelligence & Machine Learning Department, Symbiosis Institute of Technology, Pune Campus, Symbiosis International (Deemed University), Pune, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

People occasionally look to the stock market as an additional source of income. But investors face difficulties since stock market moves are inherently volatile and unpredictable. As a result, this study uses cutting-edge Deep Reinforcement Learning (DRL) approaches to increase the predictability of stock market patterns. A set of DRL models, namely Advantage Actor Critic (A2C), Proximal Policy Optimization (PPO2), and Soft Actor Critic (SAC), are utilized by utilizing data obtained from Yahoo Finance. The proposed Policy Adaptation with Trust Region Optimization (PACTRO), technique solve these issues by optimizing policy adaptation within limited trust regions. Key input components for prediction include technical indicators like the Price Chart, Moving Average Convergence Divergence (MACD), Bollinger Bands (BB), and Relative Strength Index (RSI). The created computational framework intends to deliver actionable insights, directing investors on optimal buy or sell decisions to maximize profit potential by synthesizing historical data within customized training and trading scenarios.•This study implements the Stock market prediction based on Deep Reinforcement Learning (DRL) using Technical Analysis and financials' statement.•DRL models like A2C, PPO2, and SAC, using data from Yahoo Finance, enhance investment decisions.•The proposed Policy Adaptation with Trust Region Optimization (PACTRO) method optimizes policy adaptation within trust regions.•Key technical indicators like ROC, MACD, Bollinger Bands, and RSI are crucial inputs for the prediction framework, helping guide optimal investment decisions.

Indexed as

Advantage actor criticDeep Reinforcement LearningPolicy Adaptation with Trust Region Optimization (PACTRO)Proximal policy optimizationStock market price prediction

Identifiers

PMID40207066
PMCPMC11981812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.